Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hydroxyethyl Starch 130/0.4 and Sodium Chloride Injection as Adjunctive Therapy in Subjects With Internal Carotid Artery Hypoperfusion

NCT01192581 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT01192581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01192581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hydroxyethyl Starch 130/0.4 and Sodium Chloride Injection as Adjunctive Therapy in Subjects With Internal Carotid Artery Hypoperfusion
Lead sponsor
Xijing Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
August 31, 2010
Completion date
October 31, 2011
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain hypoperfusion